OR WAIT null SECS
UBM Americas
Agnes Shanley is senior editor of Pharmaceutical Technology.
March 16, 2021
A plant inspection backlog caused by COVID-19 restrictions threatens innovation and public health. Now pressured to step up on-site inspections, will FDA embrace new methods?
February 03, 2021
New approaches to clinical trials, spurred by the COVID-19 pandemic, have dramatically shortened development timeframes. Can these gains be sustained once conditions return to normal?
February 02, 2021
From scale-up and tech transfer to analytical method development and quality testing, alliances between innovators and contract partners, and between CDMOs and technology vendors, are taking more therapies from lab to patient.
January 03, 2021
As the first wave of mRNA vaccines are distributed, efforts will be needed to protect data and prevent errors.